{"id":"NCT04672252","sponsor":"NYU Langone Health","briefTitle":"The Use of Cannabidiol (CBD) in Pain Reduction and Opioid Use After Shoulder Arthroscopy","officialTitle":"The Use of Cannabidiol (CBD) in Pain Reduction and Opioid Use After Shoulder Arthroscopy; A Double-Blind, Randomized Control Study","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2020-12-01","primaryCompletion":"2021-12-16","completion":"2022-12-16","firstPosted":"2020-12-17","resultsPosted":"2023-03-07","lastUpdate":"2023-03-07"},"enrollment":100,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pain, Postoperative"],"interventions":[{"type":"DRUG","name":"CBD Oral Disintegrating Tablet (ODT)","otherNames":[]},{"type":"OTHER","name":"Placebo ODT","otherNames":[]}],"arms":[{"label":"Cohort 1 - CBD","type":"EXPERIMENTAL"},{"label":"Cohort 2 - Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study is designed to evaluate the effects of administering CBD to control post-operative pain in patients undergoing shoulder arthroscopy. Secondly, the purpose will be to evaluate the effectiveness of CBD in comparison with opioid therapy for post-operative pain.","primaryOutcome":{"measure":"Pain Visual Analog Scale (VAS) Score","timeFrame":"Hour 24 Post-Surgery","effectByArm":[{"arm":"Cohort 1 - CBD","deltaMin":4.4,"sd":3.1},{"arm":"Cohort 2 - Placebo","deltaMin":5.7,"sd":3.2}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":23},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["38322981","35905305"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":52},"commonTop":["Elevated alanine transaminase"]}}